[Genetic analysis and individualized therapy for diffuse glioma].
Watanabe
Takao
T
Department of Neurological Surgery, Nihon University School of Medicine, Tokyo 173-8610, Japan.
Yoshino
Atsuo
A
Katayama
Yoichi
Y
D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001254:Astrocytoma / Q000188:drug therapy / Q000235:genetics; D001932:Brain Neoplasms / Q000188:drug therapy* / Q000235:genetics*; D016190:Carboplatin / Q000008:administration & dosage; D018797:Cell Cycle Proteins / Q000235:genetics; D050762:Cyclin-Dependent Kinase Inhibitor p15; D018844:Cyclin-Dependent Kinases / Q000235:genetics; D004334:Drug Administration Schedule; D005047:Etoposide / Q000008:administration & dosage; D005260:Female; D016158:Genes, p53; D005910:Glioma / Q000188:drug therapy* / Q000235:genetics*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009837:Oligodendroglioma / Q000188:drug therapy / Q000235:genetics; D046988:Proteasome Endopeptidase Complex; D011506:Proteins / Q000235:genetics; D025521:Tumor Suppressor Proteins / Q000235:genetics
C493966:CDKN2B protein, human; D018797:Cell Cycle Proteins; D050762:Cyclin-Dependent Kinase Inhibitor p15; C121623:PSMF1 protein, human; D011506:Proteins; D025521:Tumor Suppressor Proteins; D005047:Etoposide; D016190:Carboplatin; D018844:Cyclin-Dependent Kinases; D046988:Proteasome Endopeptidase Complex